World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01232231
Date of registration: 01/11/2010
Prospective Registration: No
Primary sponsor: Joseph Kim
Public title: Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting
Scientific title: Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus in the Outpatient Setting: a Randomized Controlled Study
Date of first enrolment: July 2010
Target sample size: 15
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01232231
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     Thomas J Louie, MD
Address: 
Telephone:
Email:
Affiliation:  University of Calgary
Key inclusion & exclusion criteria

Inclusion Criteria:

- Prior MRSA infection (i.e index case)

- Identified as being colonized with MRSA on initial screen

Exclusion Criteria:

- Are pregnant or breastfeeding.

- Have indwelling catheters.

- Received prior decolonization treatment within last 6 months of enrollment.

- Have allergy to study medication.

- Are colonized with MRSA strain resistant to study medication.

- Have active infection requiring systemic antimicrobials.

- Are household contacts to index case.



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Methicillin-resistant Staphylococcus Aureus
Intervention(s)
Drug: pharmacological decolonization treatment
Behavioral: Education
Primary Outcome(s)
Eradication of MRSA carriage [Time Frame: 90 days after randomization]
Secondary Outcome(s)
Occurrence of MRSA infection [Time Frame: Within 6 months of randomization]
Secondary ID(s)
E23134
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
AHS Cancer Control Alberta
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history